comparemela.com

Latest Breaking News On - Reference health - Page 1 : comparemela.com

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly .

Elmwood-park
New-jersey
United-states
New-york
Miami
Florida
Burlington
Phillip-frost
Mark-schroeder
Parker-poe
Kilpatrick-townsend
Hogan-lovells

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New-jersey
United-states
Miami
Florida
Burlington
Newfoundland
Canada
Elmwood-park
New-york
Parker-poe
Mark-schroeder
Phillip-frost

Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
New-jersey
Hogan-lovells
Kilpatrick-townsend
Parker-poe
Mark-schroeder
Phillip-frost
Piper-sandler-co
Greenberg-traurig
Bioreference-health
Nasdaq

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from the fourth quarter and subsequent weeks included the following: ModeX advanced its antiviral and immune-oncology product pipeline. ModeX advanced its pipeline of antiviral and immune-oncology programs utilizing its next-generation multispecific

Australia
Taiwan
Japan
United-arab-emirates
Canada
Miami
Florida
United-states
China
United-kingdom
Brazil
Chinese

vimarsana © 2020. All Rights Reserved.